Maturation and fertilization of nonhuman primate oocytes are compromised by oral administration of a cyclooxygenase-2 inhibitor

Diane M. Duffy, Catherine A. Vandevoort

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: To determine if oral administration of a cyclooxygenase-2 (COX2) inhibitor affects oocyte nuclear maturation and fertilization in nonhuman primates. Design: Laboratory research study. Setting: Medical school. Animal(s): Adult female cynomolgus monkeys (Macaca fascicularis). Intervention(s): Monkeys received gonadotropins to stimulate multiple follicular development. An ovulatory dose of hCG was administered either alone or with oral celecoxib, a COX2 inhibitor. Oocytes were retrieved 36 hours later and exposed to sperm in vitro. Main Outcome Measure(s): Oocytes were assessed for nuclear status at retrieval, resumption of meiosis in vitro, and success of in vitro fertilization. Result(s): Treatment with hCG alone yielded oocytes that were primarily (72.9%) at the meiosis II (MII) stage of nuclear maturation; few oocytes were obtained at the germinal vesicle and germinal vesicle breakdown stages. Treatment with hCG and celecoxib yielded fewer mature (MII) oocytes (35.6%) and more oocytes at less mature stages compared with oocytes from monkeys treated with hCG alone. The majority (68.3 ± 15.9%) of MII oocytes from monkeys treated with hCG alone fertilized in vitro, compared with only 11.0 ± 5.9% of MII oocytes from monkeys treated with hCG and celecoxib. Conclusion(s): Oral administration of a COX2 inhibitor reduced the rate of oocyte nuclear maturation and the success of in vitro fertilization. Drugs of this class may block multiple essential steps in female reproduction and be effective contraceptives for women.

Original languageEnglish (US)
Pages (from-to)1256-1260
Number of pages5
JournalFertility and Sterility
Volume95
Issue number4
DOIs
StatePublished - Mar 15 2011

Fingerprint

Cyclooxygenase 2 Inhibitors
Fertilization
Primates
Oocytes
Oral Administration
Celecoxib
Meiosis
Haplorhini
Macaca fascicularis
Fertilization in Vitro
Contraceptive Agents
Gonadotropins
Medical Schools
Reproduction
Spermatozoa
Outcome Assessment (Health Care)

Keywords

  • contraception
  • Monkey
  • ovary
  • prostaglandin

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Maturation and fertilization of nonhuman primate oocytes are compromised by oral administration of a cyclooxygenase-2 inhibitor. / Duffy, Diane M.; Vandevoort, Catherine A.

In: Fertility and Sterility, Vol. 95, No. 4, 15.03.2011, p. 1256-1260.

Research output: Contribution to journalArticle

@article{1b0af724fe594ebaa81128c0cede855d,
title = "Maturation and fertilization of nonhuman primate oocytes are compromised by oral administration of a cyclooxygenase-2 inhibitor",
abstract = "Objective: To determine if oral administration of a cyclooxygenase-2 (COX2) inhibitor affects oocyte nuclear maturation and fertilization in nonhuman primates. Design: Laboratory research study. Setting: Medical school. Animal(s): Adult female cynomolgus monkeys (Macaca fascicularis). Intervention(s): Monkeys received gonadotropins to stimulate multiple follicular development. An ovulatory dose of hCG was administered either alone or with oral celecoxib, a COX2 inhibitor. Oocytes were retrieved 36 hours later and exposed to sperm in vitro. Main Outcome Measure(s): Oocytes were assessed for nuclear status at retrieval, resumption of meiosis in vitro, and success of in vitro fertilization. Result(s): Treatment with hCG alone yielded oocytes that were primarily (72.9{\%}) at the meiosis II (MII) stage of nuclear maturation; few oocytes were obtained at the germinal vesicle and germinal vesicle breakdown stages. Treatment with hCG and celecoxib yielded fewer mature (MII) oocytes (35.6{\%}) and more oocytes at less mature stages compared with oocytes from monkeys treated with hCG alone. The majority (68.3 ± 15.9{\%}) of MII oocytes from monkeys treated with hCG alone fertilized in vitro, compared with only 11.0 ± 5.9{\%} of MII oocytes from monkeys treated with hCG and celecoxib. Conclusion(s): Oral administration of a COX2 inhibitor reduced the rate of oocyte nuclear maturation and the success of in vitro fertilization. Drugs of this class may block multiple essential steps in female reproduction and be effective contraceptives for women.",
keywords = "contraception, Monkey, ovary, prostaglandin",
author = "Duffy, {Diane M.} and Vandevoort, {Catherine A.}",
year = "2011",
month = "3",
day = "15",
doi = "10.1016/j.fertnstert.2010.12.048",
language = "English (US)",
volume = "95",
pages = "1256--1260",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Maturation and fertilization of nonhuman primate oocytes are compromised by oral administration of a cyclooxygenase-2 inhibitor

AU - Duffy, Diane M.

AU - Vandevoort, Catherine A.

PY - 2011/3/15

Y1 - 2011/3/15

N2 - Objective: To determine if oral administration of a cyclooxygenase-2 (COX2) inhibitor affects oocyte nuclear maturation and fertilization in nonhuman primates. Design: Laboratory research study. Setting: Medical school. Animal(s): Adult female cynomolgus monkeys (Macaca fascicularis). Intervention(s): Monkeys received gonadotropins to stimulate multiple follicular development. An ovulatory dose of hCG was administered either alone or with oral celecoxib, a COX2 inhibitor. Oocytes were retrieved 36 hours later and exposed to sperm in vitro. Main Outcome Measure(s): Oocytes were assessed for nuclear status at retrieval, resumption of meiosis in vitro, and success of in vitro fertilization. Result(s): Treatment with hCG alone yielded oocytes that were primarily (72.9%) at the meiosis II (MII) stage of nuclear maturation; few oocytes were obtained at the germinal vesicle and germinal vesicle breakdown stages. Treatment with hCG and celecoxib yielded fewer mature (MII) oocytes (35.6%) and more oocytes at less mature stages compared with oocytes from monkeys treated with hCG alone. The majority (68.3 ± 15.9%) of MII oocytes from monkeys treated with hCG alone fertilized in vitro, compared with only 11.0 ± 5.9% of MII oocytes from monkeys treated with hCG and celecoxib. Conclusion(s): Oral administration of a COX2 inhibitor reduced the rate of oocyte nuclear maturation and the success of in vitro fertilization. Drugs of this class may block multiple essential steps in female reproduction and be effective contraceptives for women.

AB - Objective: To determine if oral administration of a cyclooxygenase-2 (COX2) inhibitor affects oocyte nuclear maturation and fertilization in nonhuman primates. Design: Laboratory research study. Setting: Medical school. Animal(s): Adult female cynomolgus monkeys (Macaca fascicularis). Intervention(s): Monkeys received gonadotropins to stimulate multiple follicular development. An ovulatory dose of hCG was administered either alone or with oral celecoxib, a COX2 inhibitor. Oocytes were retrieved 36 hours later and exposed to sperm in vitro. Main Outcome Measure(s): Oocytes were assessed for nuclear status at retrieval, resumption of meiosis in vitro, and success of in vitro fertilization. Result(s): Treatment with hCG alone yielded oocytes that were primarily (72.9%) at the meiosis II (MII) stage of nuclear maturation; few oocytes were obtained at the germinal vesicle and germinal vesicle breakdown stages. Treatment with hCG and celecoxib yielded fewer mature (MII) oocytes (35.6%) and more oocytes at less mature stages compared with oocytes from monkeys treated with hCG alone. The majority (68.3 ± 15.9%) of MII oocytes from monkeys treated with hCG alone fertilized in vitro, compared with only 11.0 ± 5.9% of MII oocytes from monkeys treated with hCG and celecoxib. Conclusion(s): Oral administration of a COX2 inhibitor reduced the rate of oocyte nuclear maturation and the success of in vitro fertilization. Drugs of this class may block multiple essential steps in female reproduction and be effective contraceptives for women.

KW - contraception

KW - Monkey

KW - ovary

KW - prostaglandin

UR - http://www.scopus.com/inward/record.url?scp=79952442124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952442124&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2010.12.048

DO - 10.1016/j.fertnstert.2010.12.048

M3 - Article

C2 - 21236424

AN - SCOPUS:79952442124

VL - 95

SP - 1256

EP - 1260

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 4

ER -